期刊文献+

反复种植失败临床诊治中国专家共识 被引量:64

Expert consensus on diagnosis and treatment of recurrent implantation failure
原文传递
导出
摘要 反复种植失败(RIF)是一个具有挑战性的临床难题。尽管近年来体外受精-胚胎移植技术飞速发展,RIF仍是影响女性成功妊娠的重要问题,至今难以形成统一的诊疗标准。RIF病因复杂,包括母体因素、男性因素和胚胎因素,其中母体因素又包括免疫异常、血栓前状态、子宫内膜容受性不良、感染、生殖系统解剖结构异常和内分泌稳态失衡等。RIF病因的复杂性和多样性决定了在临床工作中需针对不同病因制订个性化诊疗方案。本共识将为RIF的检查、评估和管理提供建议,为医生的决策提供参考,规范RIF诊治。 Recurrent implantation failure(RIF)is a challenging clinical problem.Although in vitro fertilization-embryo transfer technology has made remarkable advances,RIF remains a significant obstacle to achieving a successful pregnancy.A unified criterion of diagnosis and treatment for RIF has yet to be created.The etiology of RIF is complicated,including maternal,male,and embryonic factors.Maternal factors include dysimmunity,prethrombotic state,poor endometrial receptivity,infection,anatomical abnormalities,and endocrine disorders.The complexity and diversity of etiologies of RIF require clinicians to individualize the strategy of diagnosis and treatment for RIF patients.This consensus will provide the most relevant evidence to date for the examination,evaluation,and management of RIF,provide a reference for clinicians to make decisions,and standardize the diagnosis and treatment of RIF.
作者 中国医师协会生殖医学专业委员会 中国女医师协会生殖医学专业委员会 李蓉 石玉华 李达 Chinese Association of Reproductive Medicine;Professional Committee of Reproductive Medicine,China Medical Women′s Association;Li Rong;Shi Yuhua;Li Da(不详;Center for Reproductive Medicine,Department of Obstetrics and Gynecology,Peking University Third Hospital,Beijing 100191,China;Center for Reproductive Medicine,Guangdong Provincial People′s Hospital,Guangdong Academy of Medical Sciences,Guangzhou 510080,China;Center for Reproductive Medicine,Shengjing Hospital of China Medical University,NHC Key Laboratory of Reproductive and Genetic Medicine,Shenyang 110022,China)
出处 《中华医学杂志》 CAS CSCD 北大核心 2023年第2期89-100,共12页 National Medical Journal of China
关键词 生殖技术 胚胎移植 反复种植失败 免疫 血栓前状态 子宫内膜容受性 共识 Reproductive techniques Embryo transfer Recurrent implantation failure Immunology Prethrombotic state Endometrial receptivity Consensus
作者简介 通信作者:李蓉,北京大学第三医院妇产科生殖医学中心,北京100191,Email:roseli001@sina.com;通信作者:石玉华,广东省人民医院生殖医学中心广东省医学科学院,广州510080,Email:shiyuhua2003@126.com;通信作者:李达,中国医科大学附属盛京医院生殖医学中心国家卫生健康委员会生殖健康与遗传医学重点实验室,沈阳110022,Email:leeda@sina.cn
  • 相关文献

参考文献8

二级参考文献101

  • 1杜乃立,戚文航.外周多巴胺受体激动剂及其应用[J].国外医学(心血管疾病分册),2000,27(3):131-133. 被引量:7
  • 2Huime JA, Lambalk CB, van Loenen AC, et al. Contemporarypharmacological manipulation in assisted reproduction. Drugs,2004,64(3):297-322.
  • 3The Practice Committee of the American Society for Repro-ductive Medicine. Use of clomiphene citrate in infertilewomen: a committee opinion. Fertil Steril, 2013,100(2):341-8.
  • 4Hajishafiha M,Dehghan M,Kiarang N, et al. Combinedletrozole and clomiphene versus letrozole and clomiphenealone in infertile patients with polycystic ovary syndrome.Drug Des Devel Ther, 2013, 7:1427-31.
  • 5Sovino H, Petermann T,Devoto L. Clomiphene citrate andovulation induction. Reprod Biomed Online, 2002, 4(3):303-10.
  • 6Clark JH, Markaverich BM. The agonistic-antagonistic prop-erties of clomiphene: a review. Pharmacol Ther, 1982,15(3):467-519.
  • 7Dickey RP, Olai* TT,Taylor SN, et al. Relationship of? endometrial thickness and pattern to fecundity in ovulationinduction cycles: effect of clomiphene citrate alone and withhuman menopausal gonadotropin. Fertil Steril, 1993, 59(4):756-60.
  • 8Brueggemeier RW. Update on the use of aromatase inhibitorsin breast cancer. Expert Opin Pharmacother, 2006,7(14):2000-11.
  • 9Mitwally MF, Casper RF. Aromatase inhibitors in ovulationinduction. Semin Reprod Med, 2004,22(1):61-78.
  • 10Kamat A, Hinshelwood MM, Murry BA, et al. Mechanismsin tissue-specific regulation of estrogen biosynthesis inhumans. Trends Endocrinol Metab, 2002,13(3):122-8.

共引文献1058

同被引文献478

引证文献64

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部